Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Cash Flow Reinvestment Rate
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Cash Flow Reinvestment Rate of 7.80x as of December 2024, reinvesting CN¥187.51 Million (capex CN¥187.14 Million plus investments CN¥369.80K) from operating cash flow of CN¥24.04 Million. Check earnings quality score of Hunan Dajiaweikang Pharmaceutical Indust to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd across 3 annual periods. Explore Hunan Dajiaweikang Pharmaceutical Indust debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2024)
Year-by-year capital reinvestment analysis for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. For live market cap and broader valuation context, see 301126 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.80x | CN¥187.51 Million | CN¥24.04 Million | CN¥187.14 Million | ▼ -9.7% |
| 2023 | 8.64x | CN¥234.43 Million | CN¥27.13 Million | CN¥226.70 Million | ▲ +1706.6% |
| 2019 | 0.48x | CN¥65.01 Million | CN¥135.91 Million | CN¥32.50 Million | — |